| Sample | Title | Value | Rank |
|---|
| GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.7527 | 99 |
| GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 10.4227 | 98 |
| GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 10.65 | 98 |
| GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.9621 | 99 |
| GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.5548 | 98 |
| GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 10.4423 | 98 |
| GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 10.3085 | 98 |
| GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 10.5132 | 98 |
| GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 10.7976 | 99 |
| GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.7084 | 99 |
| GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 10.5172 | 98 |
| GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.599 | 98 |
| GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 10.8076 | 99 |
| GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.795 | 99 |